Residential ED denied as duplicate or overlapping therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for residential ed are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UHC Denies Residential Eating Disorder Treatment as Duplicate Therapy — and Why That Denial Is Contestable

UnitedHealthcare may issue a duplicate-therapy denial for residential eating disorder (ED) treatment when a member is simultaneously enrolled in — or has recently been discharged from — another level of care, such as a partial hospitalization program (PHP) or intensive outpatient program (IOP). The insurer's position is that the services being provided in the residential setting overlap with or replicate services already being covered, making one of them redundant.

This denial reason is frequently misapplied to eating disorder treatment. Residential care for eating disorders is a distinct level of care with 24-hour medical monitoring, structured nutritional rehabilitation, and intensive psychiatric support that cannot be replicated in a day-program or outpatient setting. If the clinical record shows that lower levels of care failed to achieve or maintain stabilization — or that the member's current presentation requires the around-the-clock structure that only residential provides — the duplicate-therapy rationale collapses.

## The Federal Appeal Framework

• Internal appeal: File within 180 days of the denial. UHC must respond within 30 days (pre-service) or 60 days (post-service).
• Mental Health Parity and Addiction Equity Act (MHPAEA): Eating disorder residential treatment must be subject to the same coverage criteria UHC applies to analogous medical/surgical residential levels of care. If UHC does not apply "duplicate therapy" logic to, for example, concurrent acute inpatient and step-down sub-acute medical care, it cannot apply it to behavioral health residential treatment.
• External review (ACA §2719): After exhausting internal appeals, you have approximately 4 months to request independent external review. Expedited review is available when delay would cause serious harm.
• ERISA §503: For employer-sponsored plans, you are entitled to the specific criteria used to make the denial determination.

## Documentation to Gather

• Level-of-care justification: A clinical letter from the residential treatment team explaining what 24-hour residential care provides that cannot be duplicated at a lower level — medical monitoring, weight restoration protocols, meal support, overnight supervision.
• Prior level-of-care history: Dates and outcomes of any PHP, IOP, or outpatient treatment that preceded residential admission, showing what was attempted and why it was insufficient.
• Admission assessment: The facility's intake evaluation documenting clinical severity at the time of admission.
• Parity analysis request: Ask UHC in writing to identify the analogous medical/surgical benefit and to explain how it applies its duplicate-therapy standard to that benefit — this is a formal MHPAEA non-quantitative treatment limitation (NQTL) disclosure request.

## Criteria-Mapping Strategy

Obtain UHC's behavioral health coverage criteria for eating disorder residential care and compare them directly to its criteria for analogous medical/surgical residential levels. Document every clinical feature of the residential eating disorder admission that distinguishes it from the concurrent or prior level of care. Present each in a side-by-side chart. Emphasize the 24-hour elements — medical monitoring, overnight nursing, structured meals — that are definitionally absent from PHP/IOP. Frame the appeal around both clinical appropriateness and MHPAEA parity.